Aethlon Medical Inc. (AEMD)
NASDAQ: AEMD
· Real-Time Price · USD
0.38
-0.00 (-0.26%)
At close: May 01, 2025, 3:59 PM
0.38
-0.03%
After-hours: May 01, 2025, 05:08 PM EDT
-0.26% (1D)
| Bid | 0.36 |
| Market Cap | 6.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.56M |
| EPS (ttm) | -1.52 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | -0.71 |
| Analyst | Buy |
| Ask | 0.44 |
| Volume | 50,820 |
| Avg. Volume (20D) | 229,019 |
| Open | 0.39 |
| Previous Close | 0.38 |
| Day's Range | 0.37 - 0.39 |
| 52-Week Range | 0.24 - 1.79 |
| Beta | 1.72 |
About AEMD
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc....
Industry Medical - Devices
Sector Healthcare
IPO Date Mar 4, 1999
Employees 14
Stock Exchange NASDAQ
Ticker Symbol AEMD
Website https://www.aethlonmedical.com
Analyst Forecast
According to 1 analyst ratings, the average rating for AEMD stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 1746.48% from the latest price.
Stock Forecasts3 months ago
+18.96%
Aethlon Medical shares are trading higher after th...
Unlock content with
Pro Subscription
4 months ago
+33.83%
Aethlon Medical shares are trading higher after the company highlighted Hemopurifier's 99% in vitro capture of the H5N1 bird flu virus.
